霍亂疫苗市場規模、佔有率、成長分析，按產品類型、按給藥途徑、按最終用戶、按年齡層、按配銷通路、按地區 - 行業預測，2025-2032 年

2023 年全球霍亂疫苗市場規模為 8,020 萬美元，預計將從 2024 年的 8,670 萬美元成長到 2032 年的 1.6,166 億美元，預測期內（2025-2032 年）的複合年成長率為 8.1%。

霍亂是一種透過受污染的食物或水傳播的嚴重細菌感染疾病，是全球主要的健康威脅，其特徵是嚴重腹瀉、脫水和其他使人衰弱的症狀。霍亂感染可在數小時至數天內引起症狀，若未及時治療可能會致命。霍亂爆發的主要原因包括衛生條件差、個人衛生要求不高以及缺乏清潔飲用水。幸運的是，接種疫苗是一個重要的解決方案，透過讓人們感染少量活霍亂細菌來增強免疫力。疫苗接種可以透過靜脈注射、肌肉注射或口服等多種方式進行，在世界衛生組織（WHO）等組織建議的對抗這種感染疾病的公共衛生策略中發揮關鍵作用。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

霍亂疫苗市場規模（按類型）

• 市場概況
• 全細胞霍亂弧菌 O1 和重組 B 次單位疫苗
• 去活化口服疫苗（去活化口服 O1 和 O139 流感病毒）

霍亂疫苗市場規模（按產品）

• 市場概況
• Vaxchora
• Dukoral
• Shanchol
• 其他產品

霍亂疫苗市場規模（依接種途徑）

• 市場概況
• 注射疫苗
• 口服疫苗

霍亂疫苗市場規模（以最終用戶分類）

• 市場概況
• 醫院
• 居家護理
• 專科門診
• 其他

霍亂疫苗市場規模（依年齡層分類）

• 市場概況
• 成人
• 孩子

霍亂疫苗市場規模（按分銷管道）

• 市場概況
• 醫院藥房
• 網路藥局
• 零售藥局

霍亂疫苗市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Valneva SE（France）
• Sanofi（France）
• Emergent BioSolutions（USA）
• EuBiologics（South Korea）
• Shantha Biotechnics（India）
• Hilleman Laboratories（Singapore）
• Astellas Pharma（Japan）
• Incepta Vaccine（Bangladesh）
• Vabiotech（France）
• Bharat Biotech（India）
• Biological E.（India）
• Serum Institute of India（India）
• Panum Institute（Denmark）
• Walter Reed Army Institute of Research（USA）
• National Institutes of Health（NIH）（USA）
• World Health Organization（WHO）（Switzerland）
• Centers for Disease Control and Prevention（CDC）（USA）
• Medecins Sans Frontieres（MSF）（Switzerland）
• PATH（USA）

結論和建議

Global Cholera Vaccines Market size was valued at USD 80.2 million in 2023 and is poised to grow from USD 86.7 million in 2024 to USD 161.66 million by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

Cholera, a serious bacterial infection transmitted through contaminated food and water, poses a significant global health threat marked by severe diarrhea, dehydration, and other debilitating symptoms. The Vibrio cholera bacterium causes this illness, which can manifest within hours to days, and can be fatal if not treated promptly. Key contributors to cholera outbreaks include poor hygiene, inadequate sanitation, and lack of access to clean drinking water. Fortunately, vaccination offers a vital solution, promoting immunity by exposing individuals to a small number of live cholera bacteria. Administered through various methods including intravenous, intramuscular, or oral routes, cholera vaccines are instrumental in combating this infectious disease, playing a crucial role in public health strategies endorsed by organizations like the World Health Organization.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cholera Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cholera Vaccines Market Segments Analysis

Global Cholera Vaccines Market is segmented by Type, Product, Route of Administration, End User, Age Group, Distribution Channel and region. Based on Type, the market is segmented into Whole Cell V. Cholerae O1 with Recombinant B- subunit and Killed Oral O1 and O139. Based on Product, the market is segmented into Vaxchora, Dukoral, Shanchol and Other Products. Based on Route of Administration, the market is segmented into Injectables Vaccines and Oral Vaccines. Based on End User, the market is segmented into Hospitals, Homecare, Specialty Clinics and Others. Based on Age Group, the market is segmented into Adults and Children. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Online Pharmacy and Retail Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cholera Vaccines Market

The growth of the global cholera vaccines market is primarily driven by innovative approaches in developing new vaccines, heightened awareness surrounding cholera prevention, and the prevalence of unhealthy lifestyle choices, such as inadequate sanitation and consumption of contaminated food. Furthermore, intensified government initiatives and vaccination campaigns have bolstered market expansion. However, the market may face challenges due to stringent FDA regulations and an extended approval timeline for new pharmaceutical products, which can impede the introduction of potentially effective cholera vaccines. Overall, the interplay of these factors shapes the dynamic landscape of the cholera vaccines market on a global scale.

Restraints in the Global Cholera Vaccines Market

One of the major factors hindering the growth of the global cholera vaccines market is the prolonged time required for vaccine development, coupled with the stringent regulatory approval processes in place. These challenges can create delays in bringing new vaccines to market, which may ultimately impact the availability of effective cholera prevention methods. As a result, these factors can constrain the overall expansion and accessibility of cholera vaccines, especially in regions where the disease is prevalent. Consequently, addressing these hurdles is crucial for enhancing the market's growth trajectory and improving public health outcomes related to cholera.

Market Trends of the Global Cholera Vaccines Market

The global cholera vaccines market is experiencing a significant upward trend, propelled by the alarming rise in cholera cases linked to inadequate sanitation and hygiene, particularly in rural and remote regions. As cholera outbreaks become more prevalent, public health initiatives and governmental support are heightening awareness about the critical role of vaccination in combatting this preventable disease. The increasing focus on disease prevention, coupled with advancements in vaccine technology and distribution strategies, is further driving demand. Moreover, collaborative efforts between organizations and health authorities to enhance accessibility underpin a promising growth trajectory for the cholera vaccines market in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cholera Vaccines Market Size by Type & CAGR (2025-2032)

• Market Overview
• Whole Cell V. Cholerae O1 with Recombinant B- subunit
• Killed Oral O1 and O139

Global Cholera Vaccines Market Size by Product & CAGR (2025-2032)

• Market Overview
• Vaxchora
• Dukoral
• Shanchol
• Other Products

Global Cholera Vaccines Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Injectables Vaccines
• Oral Vaccines

Global Cholera Vaccines Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Homecare
• Specialty Clinics
• Others

Global Cholera Vaccines Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Adults
• Children

Global Cholera Vaccines Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Global Cholera Vaccines Market Size & CAGR (2025-2032)

• North America (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • US
  • Canada
• Europe (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Route of Administration, End User, Age Group, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Valneva SE (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EuBiologics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shantha Biotechnics (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hilleman Laboratories (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Incepta Vaccine (Bangladesh)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vabiotech (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biological E. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serum Institute of India (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panum Institute (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Walter Reed Army Institute of Research (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• National Institutes of Health (NIH) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• World Health Organization (WHO) (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Centers for Disease Control and Prevention (CDC) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medecins Sans Frontieres (MSF) (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PATH (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations